Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

In March 2024, a U.S. court in Illinois awarded $60 million in damages to a mother of a baby that died from necrotizing ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing ...

The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...

Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...

Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for ...

RBC estimates that Reckitt could be facing up to £2bn of liabilities in relation to NEC claims. Reckitt has placed the Mead Johnson business, which it bought in 2017 for $18bn (£13.9bn), under review.